Nomura Asset Management CO LTD Supernus Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

9 transactions

Quarter	Operation	Price Per share	shares change
Q2 2019 Aug 13, 2019	SELL	$29.96 - $38.87 $0 - $0	0 Closed
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$30.84 - $49.51 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$42.7 - $56.55 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$44.1 - $59.85 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$37.15 - $46.9 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $0 - $0	0 New
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $0 - $0	0

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.